EP3641772
TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.6.2018EP published:
2.8.2023EP application number:
18819790.9
EPO information:
European Patent Register
Max expiry date:
20.6.2038
Title in English:
TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTIONLanguage of the patent:
English
Timeline
Today
21.6.2018EP application
2.8.2023EP Publication
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Inventor
Name:
FILVAROFF, EllenAddress:
San Francisco CA 94121, US
Name:
HEGE, Kristen, M.Address:
Burlingame CA 94010, US
Name:
LI, ShaoyiAddress:
Warren NJ 07059, US
Priority
Number:
201762523688 PDate:
22.6.2017Country:
US
Classification
Categories:
A61K 31/4985, A61P 31/12, A61P 35/00, A61K 31/44, G01N 33/50